Blog

Narjust Florez and Alfredo Addeo dive into the data from ESMO – IASLC

The International Association for the Study of LungCancer/X

Jan 16, 2025, 10:01

Narjust Florez and Alfredo Addeo dive into the data from ESMO – IASLC

The International Association for the Study of Lung Cancer shared a post on X:

“New Episode Alert.

In the latest Lung Cancer Considered, Narjust Florez and Alfredo Addeo dive into the data from the European Society for Medical Oncology (ESMO).

Discover insights from Geneva on the evolving field of Immuno-Oncology.

Listen here.”

More posts featuring IASLC.

Alfredo Addeo cancer European Society for Medical Oncology Geneva immuno-oncology Lung cancer Lung Cancer Considered Narjust Florez OncoDaily Oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage